Matches in Wikidata for { <http://www.wikidata.org/entity/Q82654452> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q82654452 description "2012 թվականի հունվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q82654452 description "article scientifique publié en 2012" @default.
- Q82654452 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q82654452 description "bài báo khoa học" @default.
- Q82654452 description "im Januar 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82654452 description "scientific article published on 11 January 2012" @default.
- Q82654452 description "wetenschappelijk artikel" @default.
- Q82654452 description "наукова стаття, опублікована в січні 2012" @default.
- Q82654452 name "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 name "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 type Item @default.
- Q82654452 label "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 label "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 prefLabel "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 prefLabel "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 P1433 Q82654452-A2026E70-80DA-414B-9794-15F5313BD620 @default.
- Q82654452 P1476 Q82654452-3A839F2E-5305-4838-91B5-83A01B9FD8B5 @default.
- Q82654452 P2093 Q82654452-1E697BA6-1BC5-473C-8ED1-3EA521900FDB @default.
- Q82654452 P2093 Q82654452-2C8470F8-F28D-46C2-9A66-1E6F6E6EDAD7 @default.
- Q82654452 P2093 Q82654452-393E4722-6C31-4971-988E-F356D209260D @default.
- Q82654452 P2093 Q82654452-4B949D65-5803-43AB-BF9C-B0F0D6CCA2CB @default.
- Q82654452 P2093 Q82654452-569F9AFE-38CB-4774-9AF5-A7CB926628C6 @default.
- Q82654452 P2093 Q82654452-C53C9A7D-77D2-42BB-9FC5-37A3F6F2D335 @default.
- Q82654452 P304 Q82654452-4557E839-77FA-4F01-B731-5E300152797E @default.
- Q82654452 P31 Q82654452-78070D54-EE66-4397-AACB-6DCE615BE7D0 @default.
- Q82654452 P356 Q82654452-05152326-3A02-4008-80F7-C97FBEBD77A9 @default.
- Q82654452 P433 Q82654452-72A2EBEB-85F9-4C9B-8727-658683347DA9 @default.
- Q82654452 P478 Q82654452-26BE479B-93E6-4B6C-B32F-B6FA59688030 @default.
- Q82654452 P50 Q82654452-02917CEA-6540-43FA-A7A6-7E3D96233E2B @default.
- Q82654452 P50 Q82654452-083B9BFD-BA1C-4FC8-A8D8-9A69DEE42F60 @default.
- Q82654452 P50 Q82654452-0DFB2144-B409-41F4-B602-2DAE10B82FCB @default.
- Q82654452 P50 Q82654452-2E8857F8-301B-4C13-A04A-F835A1DA6C6E @default.
- Q82654452 P50 Q82654452-B7212E76-B471-4213-AEF1-67B86C71D17C @default.
- Q82654452 P577 Q82654452-51B462B3-0CD5-4578-9DB4-DE3891DFF211 @default.
- Q82654452 P698 Q82654452-0E24D11A-37A1-4C74-AED3-CF4B8D799129 @default.
- Q82654452 P921 Q82654452-18E20A5B-A8C9-4651-B748-FAD7554F5360 @default.
- Q82654452 P921 Q82654452-599219CE-3A3E-46C7-AA30-102C867A2B6F @default.
- Q82654452 P921 Q82654452-610D7DC1-C654-4BF3-8C8D-3D9DC7692886 @default.
- Q82654452 P921 Q82654452-E9F35559-A7BE-4C52-95F9-D34E366123A4 @default.
- Q82654452 P356 10428194.2011.643407 @default.
- Q82654452 P698 22111969 @default.
- Q82654452 P1433 Q6534493 @default.
- Q82654452 P1476 "Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice" @default.
- Q82654452 P2093 "Gregor Verhoef" @default.
- Q82654452 P2093 "Kate Bendall" @default.
- Q82654452 P2093 "Pieternella J Lugtenburg" @default.
- Q82654452 P2093 "Ruth Pettengell" @default.
- Q82654452 P2093 "Ulrich Duehrsen" @default.
- Q82654452 P2093 "Ulrich Jaeger" @default.
- Q82654452 P304 "982-984" @default.
- Q82654452 P31 Q13442814 @default.
- Q82654452 P356 "10.3109/10428194.2011.643407" @default.
- Q82654452 P433 "5" @default.
- Q82654452 P478 "53" @default.
- Q82654452 P50 Q38292884 @default.
- Q82654452 P50 Q42409674 @default.
- Q82654452 P50 Q43196325 @default.
- Q82654452 P50 Q57692540 @default.
- Q82654452 P50 Q59200159 @default.
- Q82654452 P577 "2012-01-11T00:00:00Z" @default.
- Q82654452 P698 "22111969" @default.
- Q82654452 P921 Q18936 @default.
- Q82654452 P921 Q2626074 @default.
- Q82654452 P921 Q412323 @default.
- Q82654452 P921 Q4833719 @default.